By: Amanda Kastel, PharmD Candidate c/o 2027 On September 22, 2025, President Donald Trump and HHS Secretary Robert F. Kennedy Jr. held a press conference that sparked widespread confusion among medical professionals and the public. Roughly three minutes into the briefing, President Trump announced that the FDA would notify physicians about a “very increased risk”…

Continue reading →

By: Sariah Grant PharmD Candidate c/o 2027 Color additives have long played a crucial role in the appearance and appeal of many foods and pharmaceutical products.1 From vibrant candies to easily identifiable medications, synthetic dyes such as Food, Drug and Cosmetics (FD&C) Red Dye No.3, have been used for decades. However, growing concerns over its safety…

Continue reading →

By: Nivaj Haque PharmD Candidate c/o 2027 The pharmaceutical industry is undergoing significant changes in the background as new government policies are affecting the development, approval, and sale of drugs. These changes are affecting the staffing at the regulatory agencies, drug pricing, and international trade. They are also affecting pharmaceutical companies, healthcare providers and patients…

Continue reading →